Cargando…
Synergistic Anti-Tumour Effect of Syk Inhibitor and Olaparib in Squamous Cell Carcinoma: Roles of Syk in EGFR Signalling and PARP1 Activation
Syk is a non-receptor tyrosine kinase involved in the signalling of immunoreceptors and growth factor receptors. Previously, we reported that Syk mediates epidermal growth factor receptor (EGFR) signalling and plays a negative role in the terminal differentiation of keratinocytes. To understand whet...
Autores principales: | Huang, Duen-Yi, Chen, Wei-Yu, Chen, Chi-Long, Wu, Nan-Lin, Lin, Wan-Wan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072502/ https://www.ncbi.nlm.nih.gov/pubmed/32093123 http://dx.doi.org/10.3390/cancers12020489 |
Ejemplares similares
-
PKC-Dependent Human Monocyte Adhesion Requires AMPK and Syk Activation
por: Chang, Mei-Ying, et al.
Publicado: (2012) -
Postnatal Syk deletion in mice clarifies the function of Syk in an anti-collagen antibody-induced arthritis model
por: Ozaki, Naoko, et al.
Publicado: (2012) -
SYK Allelic Loss and the Role of Syk-Regulated Genes in Breast Cancer Survival
por: Blancato, Jan, et al.
Publicado: (2014) -
Syk inhibitors in clinical development for hematological malignancies
por: Liu, Delong, et al.
Publicado: (2017) -
Identification of Inhibitors of Integrin Cytoplasmic Domain Interactions With Syk
por: Bakthavatsalam, Deenadayalan, et al.
Publicado: (2021)